Divi’s Labs Signs Long-Term Supply Deal with Global Pharma Company
ECONOMY & POLICY

Divi’s Labs Signs Long-Term Supply Deal with Global Pharma Company

Divi’s Laboratories Ltd has entered into a long-term supply agreement with a global pharmaceutical company for the manufacture and delivery of advanced intermediates, the company said in a regulatory filing on Friday.

Though the identity of the global partner was not disclosed, Divi’s stated that it expects meaningful revenue contribution from the arrangement. To support this agreement and future growth, the company plans to invest between Rs 6.5 billion and Rs seven billion in capacity addition at its manufacturing facilities. The expansion will be funded entirely through internal accruals.

This move is seen as a strategic step towards strengthening Divi’s position in the global pharmaceutical supply chain and scaling up production capabilities. The firm, known for supplying active pharmaceutical ingredients and intermediates, has previously maintained long-standing partnerships with several multinational drug makers.

Shares of Divi’s Laboratories closed 2.07 per cent lower at Rs 5,638.35 apiece on the Bombay Stock Exchange.

Source: Press Trust of India

Divi’s Laboratories Ltd has entered into a long-term supply agreement with a global pharmaceutical company for the manufacture and delivery of advanced intermediates, the company said in a regulatory filing on Friday. Though the identity of the global partner was not disclosed, Divi’s stated that it expects meaningful revenue contribution from the arrangement. To support this agreement and future growth, the company plans to invest between Rs 6.5 billion and Rs seven billion in capacity addition at its manufacturing facilities. The expansion will be funded entirely through internal accruals. This move is seen as a strategic step towards strengthening Divi’s position in the global pharmaceutical supply chain and scaling up production capabilities. The firm, known for supplying active pharmaceutical ingredients and intermediates, has previously maintained long-standing partnerships with several multinational drug makers. Shares of Divi’s Laboratories closed 2.07 per cent lower at Rs 5,638.35 apiece on the Bombay Stock Exchange. Source: Press Trust of India

Next Story
Technology

HCL-Foxconn to invest Rs 37 billion in chip plant near Jewar airport

The Union Cabinet has approved the establishment of a new semiconductor unit near Jewar airport in Uttar Pradesh under the India Semiconductor Mission. This sixth plant, a joint venture between HCL and Foxconn, marks further progress in India’s semiconductor journey. The project will see an investment of Rs 37 billion.The facility will produce display driver chips for mobile phones, laptops, automobiles, PCs, and other digital devices. It is designed for a monthly capacity of 20,000 wafers and an output of 36 million units.Five semiconductor units are already in advanced stages of constructi..

Next Story
Real Estate

Brigade acquires Velachery land for Rs 16-billion project

Brigade Enterprises has acquired a 5.41-acre land parcel on Velachery Road, Chennai, through an outright purchase for Rs 4.417 billion. Located next to Phoenix Market City, the site will be developed into a premium residential project with a gross development value of approximately Rs 16 billion and a development potential of 0.8 million square feet.The project offers strategic access to both the OMR IT Corridor and Chennai’s Central Business District, promising strong connectivity and premium lifestyle offerings. Brigade plans to create signature residences focused on aesthetics, functional..

Next Story
Equipment

Liebherr marks 10,000th XPower wheel loader milestone

Liebherr-Werk Bischofshofen has rolled out its 10,000th XPower wheel loader, marking a major production milestone. The anniversary L 580 XPower model, featuring a power-split travel drive developed with ZF Friedrichshafen AG, was handed over to the BERGER Group in Passau.“The transmission from our partner ZF is a key component of the drivetrain in our XPower wheel loaders,” said Gerhard Pirnbacher, Head of Quality Management at Liebherr. “With an impressive total of around 64 million operating hours already clocked up by XPower models, this transmission has proven its exceptional robustn..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?